COG Nordics brings together experts from leading pharmaceutical and biopharmaceutical companies to explore the latest innovations and challenges in clinical development. If you are attending COG Nordics, stop by booth #2 and say hello to our team.
Matt Cooper, PhD, Executive Director, Therapeutic Strategy Lead, Oncology, will be presenting “The Global Biotech Market – Emerging Trends” on 1 April at 10am CES. In this session Matt will share insights into the health of the global biotech market and will explore:
Where is the market at now
How to best position your clinical program for the market
Emerging trends and growth areas from the perspective of the oncology market
Matt Cooper is the Executive Director, Therapeutic Strategy Lead, Oncology and has 25 years of experience in the life science industry conducting clinical trials across all phases. His experience spans roles at sponsors, sites, and the NHS, and he has extensive experience in site management and expanded use of oncology therapies. He is passionate about building effective relationships between industry stakeholders to drive innovation and patient access.
Worldwide Clinical welcomes you to our site. We collect information about your browsing experience such as cookies, pixels, and web beacons (collectively, “cookies”) to assist with improving your experience with our website. You may ‘Agree’ to accept categories of cookies or ‘Decline’ to reject optional cookies. Worldwide uses Essential Cookies, thus you may not opt of these Cookies as they are deployed to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For additional information on the categories of data we collect, the purposes for their collection, disclosures to third parties, and data retention, please visit our Privacy Policy or Cookie Notice for more information.